Lexicon stock tumbles after FDA AdCom votes against Zynquista again
The US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (AdCom) has again voted against the approval …
The US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (AdCom) has again voted against the approval …
The world of clinical trials is undergoing a rapid change. Today, the rise of decentralized clinical trials (DCTs) and hybrid …
Leaders from the National Comprehensive Cancer Network (NCCN) alliance of US cancer centres are in Vietnam today (1 November) as …
Verastem Oncology has concluded the rolling submission of a new drug application (NDA) to the US Food and Drug Administration …
The US District Court for the District of Columbia has upheld the decision by the US Food and Drug Administration …
AbbVie has entered into a partnership and option-to-license agreement with EvolveImmune Therapeutics, to develop next-generation cancer biotherapeutics. The partnership will focus on …
The European Commission (EC) has imposed a fine of €462.6m ($502m) on Teva Pharmaceuticals Industries after investigating the company’s practices …
Matinas BioPharma has halted all product development activities and fired 80% of its staff, including three members of senior management, …
Amgen has announced a total revenue of $8.5bn in Q3 2024, a 23% increase from a $6.9bn revenue in the …
Announcing the UK's Budget yesterday (30 October), Rachel Reeves outlined the Labour Party’s investment plans for research and development (R&D) …
As biosimilars continue to arrive on the psoriasis scene, wider measures to influence drug access and emerging treatment choices in …
On October 24, Dyno Therapeutics announced the formation of a new strategic partnership with Roche to develop adeno-associated virus (AAV) …
The number of incident cases of bladder cancer in the eight major markets is set to increase, with men and …
Biogen and Neomorph have entered a research partnership aimed at discovering and developing molecular glue degraders for the treatment of …
Geopolitical events and economic fluctuations have impacted the pharmaceutical industry, inducing a wave of layoffs that have hit both pharma …